Remove solutions decentralized-solutions
article thumbnail

Online event centers on decentralized study solutions

Outsourcing Pharma

Taking place July 20, the Decentralized Trial Technology webinar will share insights and experiences from a group of knowledgeable virtual trial experts.

Trials 52
article thumbnail

IQVIA expands reach of its decentralized trial solutions

Outsourcing Pharma

The company reports that its patient-centric virtual study technology currently is in use in more than 60 ongoing trials in over 40 different countries.

Trials 65
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medable unveils eConsent solution for decentralized trials

Outsourcing Pharma

TeleConsent empowers trial teams to obtain informed consent and re-consent from patients participating in clinical studies, within a fully remote system.

Trials 52
article thumbnail

Intelligent eCOA use enhances trials, amplifies patient voice: Medable

Outsourcing Pharma

An expert from the decentralized trial solutions company shares how eCOA and ePRO can be useful tools that improve the collection and quality of such data.

Trials 81
article thumbnail

Increased representation benefits cancer clinical trials: Science 37

Outsourcing Pharma

An expert from the decentralized study solutions company shares perspectives on the importance of inclusivity and solutions that could improve representation.

article thumbnail

Castor bolsters trial solutions platforms to reach more patients and gain RWE

Outsourcing Pharma

Castor adds to its existing decentralized and hybrid clinical trial solutions platform to collect RWE, expand trials to global populations, and integrate virtual trial visits.

Trials 52
article thumbnail

Parexel, Medidata extend decentralized clinical trial partnership

Outsourcing Pharma

The two companies, which have been collaborating for 15 years, reportedly will focus on elevating decentralized trial solutions to develop new therapies.